Inhaler items

Abstract

An inhaler article (10) is provided having an upstream end (1) and a downstream end (2). The inhaler article includes an upstream section (3) including an end plug (5). The inhaler article includes a downstream section (4) located downstream of and spaced apart from the upstream section. The downstream section includes a filter segment (6). The filter segment has a resistance to withdrawal per unit length greater than 0 millimeters of water column per millimeter and less than about 3 millimeters of water column per millimeter. The inhaler article includes a cavity (7) defined between the upstream section and the downstream section and configured to be in fluid communication with the exterior of the article. The inhaler article includes a capsule (9) containing an inhalable material and positioned within the cavity. An inhaler system (100) including such an inhaler article and a holder (120) is also provided.

Description

[Technical Field]

[0001] The present disclosure relates to an inhaler article having a particular filter segment. The present disclosure also relates to an inhaler system including a holder for receiving the inhaler article and the inhaler article. [Background technology]

[0002] Inhaler articles such as dry powder inhalers are not always fully adequate to deliver dry powder particles to the lungs at inhalation volumes or airflow rates that are within the range of inhalation volumes or airflow rates of traditional smoking methods. Dry powder inhalers can be complicated to operate or involve moving parts. Dry powder inhalers often attempt to deliver an adequate dry powder dose or capsule load in a single draw.

[0003] Some dry powder inhalers have a component for storing dry powder, such as a capsule. The capsule may be located within the inhaler and can be activated by being pierced by a separate piercing element. When the capsule is activated, the consumer may suck on the mouth end (downstream or proximal end) of the inhaler so that the capsule rotates around itself, generating airflow through the inhaler. The agitation of the capsule within the inhaler article and the airflow pressure release the dry powder from the pierced capsule. The released dry powder is carried by the airflow to the user's mouth.

[0004] Some inhaler articles include a retaining segment located downstream of the capsule. The retaining or supporting segment is primarily intended to hold the capsule in the inhaler. The retaining segment may be hollow or porous to allow dry powder to pass through. However, some retaining or supporting segments that are hollow or relatively porous may allow a relatively large amount of dry powder to pass through. This may mean that when a consumer inhales the article, the dose is too large, resulting in premature depletion of the capsule, potentially adversely affecting the consumer's experience. Alternatively, the retaining element or segment may have a relatively low porosity, which may prevent the consumer from properly depleting the capsule, given the relatively high withdrawal resistance of the inhaler article and the relatively small volume withdrawn by the consumer.

[0005] Furthermore, the upstream (distal) end of the retaining segment of a capsule-containing inhaler article withstands considerable axial force during the capsule activation process. During this activation process, a piercing element extends into the upstream end of the inhaler article to contact and penetrate the capsule located within the article. Upon first contact, the piercing element presses the capsule against the upstream end of the retaining (or support) segment to successfully penetrate the capsule. Thus, the downstream components of the inhaler article, particularly the retainer segment, should be relatively resistant to deformation, particularly in the longitudinal direction, especially under compression, while also being sufficiently porous or having appropriately sized airflow channels so that the resistance to withdrawal (RTD) of the inhaler article ensures a pleasant consumer experience.

[0006] To provide a satisfying experience for consumers of inhalers or aerosol-generating articles, it is desirable to provide an inhaler article that is cost-effective, quick to manufacture, and operates effectively by ensuring reliable capsule depletion during use. Summary of the Invention

[0007] According to one aspect of the present disclosure, an inhaler article is provided having an upstream end and a downstream or mouth end. The inhaler article includes an upstream section. The upstream section includes an end plug. The inhaler article includes a downstream section located downstream of the upstream section and spaced apart from the upstream section. The downstream section includes a filter segment (also called a support segment or mouthpiece segment). The filter segment has a draw resistance per unit length greater than 0 millimeters of water per millimeter (mm) (also expressed as millimeters water, mmH20, mm water, mm water gauge, mmWG, or mm of water) and less than about 3 millimeters of water per millimeter. This may be similar or equivalent to the draw resistance of a conventional cigarette or a conventional dry powder inhaler. The inhaler article includes a cavity defined between the upstream section and the downstream section. The cavity is configured to be in fluid communication with the exterior of the inhaler article. The inhaler article includes a capsule containing an inhalable material. The capsule is located within the cavity.

[0008] According to one aspect of the present disclosure, an inhaler article is provided having an upstream end and a downstream end. The inhaler article may include an upstream section. The upstream section may include an end plug. The inhaler article may include a downstream section located downstream of the upstream section and separated from the upstream section by a gap. The downstream section may include a mouthpiece segment or a filter segment. The mouthpiece segment or filter segment may have a resistance to withdrawal per unit length greater than 0 mm of water column per mm and less than about 3 mm of water column per mm. The inhaler article may include a cavity defined between the upstream section and the downstream section. The cavity may be configured to accommodate a capsule containing an inhalable material. The cavity may be configured to be in fluid communication with the exterior of the inhaler article.

[0009] The inhaler article may comprise a capsule containing the inhalable material. The capsule may be located within the cavity.

[0010] According to one aspect of the present disclosure, there is also provided a mouthpiece segment or filter segment for use in an inhaler article or any other aerosol-generating article, wherein the mouthpiece segment or filter segment may have a resistance to withdrawal per unit length greater than 0 mm of water column per mm and less than about 3 mm of water column per mm.

[0011] It has been found that providing a filter segment downstream of the capsule with a resistance to withdrawal (RTD) of about 0 mm of water per mm to about 3 mm of water per mm is advantageous in ensuring that the RTD characteristics of the filter segment allow the user to generate adequate airflow, thereby providing an adequate airflow rate to achieve effective depletion of the inhalable material contained within the capsule.

[0012] The "filter segment" of the inhaler article may alternatively be referred to in this disclosure as the "support segment," "mouthpiece segment," "retainer segment," "downstream segment," or "downstream section" of the inhaler article. A cavity is preferably defined between the upstream section and the filter segment, more preferably between the end plug and the filter segment.

[0013] The terms "upstream" and "downstream" refer to the relative locations of the holder, inhaler article, and inhaler system elements described in relation to the direction of inhaled airflow as it is drawn through the inhaler article, holder, and inhaler system. "Downstream" is the oral end. "Upstream" is distal to the oral end.

[0014] The term "longitudinal" refers to a direction corresponding to the major longitudinal axis of the inhaler article or inhaler system extending between the upstream end and the downstream end. During use, air is drawn longitudinally through the aerosol-generating article or inhaler article from the upstream end to the downstream end. The term "transverse" refers to a direction perpendicular to the longitudinal axis. Any reference to a "cross-section" of the inhaler article or a component thereof refers to a transverse cross-section unless otherwise specified. The term "length" refers to the dimension of the aerosol-generating article or a component of the inhaler article in the longitudinal direction. For example, it may be used to refer to the dimension of a capsule or filter segment in the longitudinal direction. The term "tangential" refers to a direction at an angle from the referenced direction. For example, a tangential angle is non-parallel to the referenced direction.

[0015] The terms "proximal" and "distal" are used to describe the relative positions of components or portions of components of an inhaler article, holder, or inhaler system. According to the present disclosure, the holder or an element forming the holder (such as a sleeve) has a proximal end that receives the inhaler article during use and an opposing distal end that may be closed or have an end closer to the proximal end of the holder. According to the present disclosure, the inhaler article has a proximal end. During use, nicotine particles exit the proximal end of the inhaler article for delivery to the user. The inhaler has a distal end opposite the proximal end. The proximal end of the inhaler article may also be referred to as the mouth end or downstream end. The distal end of a component may correspond to the upstream end of such component. The mouth end of a component may also correspond to the downstream end of such component.

[0016] Unless otherwise specified, the resistance to draw (RTD) of a component or inhaler article is measured in accordance with ISO 6565-2015. RTD refers to the pressure required to force air through the entire length of the component. The terms "pressure drop" or "draw resistance" of a component or article can also refer to "resistance to draw." These terms typically refer to measurements in accordance with ISO 6565-2015 performed under a temperature of about 22 degrees Celsius, a pressure of about 101 kPa (about 760 Torr), and a relative humidity of about 60%, with a volumetric flow rate of about 17.5 milliliters / second at the output or downstream end of the component being measured.

[0017] The resistance to withdrawal per unit length of a particular component, such as a filter segment, can be calculated by dividing the measured resistance to withdrawal of the component by the total axial length of the component. RTD per unit length refers to the pressure required to force air through a unit length of the component. Throughout this disclosure, unit length refers to a length of 1 mm. Therefore, to derive the RTD per unit length of a particular filter segment, a particular length, e.g., a 15 mm specimen of the filter segment, can be used for measurement. The RTD of such a specimen is measured according to ISO 6565-2015. For example, if the measured RTD is approximately 15 mm of water column, the RTD per unit length of the filter segment is approximately 1 mm of water column per mm. The RTD per unit length of a filter segment depends, among other factors, on the structural characteristics of the material used in the filter segment as well as the cross-sectional shape or profile of the filter segment.

[0018] The relative RTD or RTD per unit length of the filter segment may be from about 0 mm of water column per mm to about 3 mm of water column per mm. Alternatively, the RTD per unit length of the filter segment may be from about 0 mm of water column per mm to about 2.5 mm of water column per mm. Alternatively, the RTD per unit length of the filter segment may be from about 0 mm of water column per mm to about 2 mm of water column per mm. The RTD per unit length of the filter segment may be from about 0 mm of water column per mm to about 1 mm of water column per mm. The RTD per unit length of the filter segment may be from about 0 mm of water column per mm to about 0.75 mm of water column per mm.

[0019] As described above, the relative RTD or RTD per unit length of the filter segment may be greater than about 0 mm of water column per mm and less than about 3 mm of water column per mm. Alternatively, the RTD per unit length of the filter segment may be greater than about 0 mm of water column per mm and less than about 2.5 mm of water column per mm. Alternatively, the RTD per unit length of the filter segment may be greater than about 0 mm of water column per mm and less than about 2 mm of water column per mm. The RTD per unit length of the filter segment may be greater than about 0 mm of water column per mm and less than about 1 mm of water column per mm. The RTD per unit length of the filter segment may be greater than about 0 mm of water column per mm and less than about 0.75 mm of water column per mm.

[0020] The RTD per unit length of the filter segment may be greater than 0.01 mm of water column per mm. Thus, the RTD per unit length of the filter segment may be between about 0.01 mm of water column per mm and about 3 mm of water column per mm. Alternatively, the RTD per unit length of the filter segment may be between about 0.01 mm of water column per mm and about 2.5 mm of water column per mm. Alternatively, the RTD per unit length of the filter segment may be between about 0.01 mm of water column per mm and about 2 mm of water column per mm. The RTD per unit length of the filter segment may be between about 0.01 mm of water column per mm and about 1 mm of water column per mm. The RTD per unit length of the filter segment may be between about 0.01 mm of water column per mm and about 0.75 mm of water column per mm.

[0021] The resistance to withdrawal of the filter segment may be greater than 0 mm of water column and less than about 20 mm of water column. The resistance to withdrawal of the filter segment may be greater than 0 mm of water column and less than about 15 mm of water column. The resistance to withdrawal of the filter segment may be greater than 0 mm of water column and less than about 10 mm of water column. The resistance to withdrawal of the filter segment may be greater than 0 mm of water column and less than about 10 mm of water column.

[0022] The filter segment can be configured to withstand a force of up to about 15 Newtons applied to its upstream end without substantial longitudinal deformation. As described above, the filter segment located downstream of the capsule must be configured to withstand the compressive force applied by the capsule on the upstream end of the filter segment during the activation of the capsule. Therefore, the filter segment can be sufficiently rigid to withstand such activation of the capsule. The filter segment can include a rigid material.

[0023] The filter segment may be configured to withstand a force of up to about 12 Newtons applied to its upstream end without substantial longitudinal deformation. The filter segment may be configured to withstand a force of up to about 7 Newtons applied to its upstream end without substantial deformation. The filter segment may be configured to withstand a force of at least about 3 Newtons applied to its upstream end without substantial deformation. The filter segment may be configured to withstand a force of at least about 3 Newtons to about 15 Newtons applied to its upstream end without substantial deformation. The filter segment may be configured to withstand a force of at least about 3 Newtons to about 12 Newtons applied to its upstream end without substantial deformation. Ensuring that the filter segment can withstand any of these ranges of force applied to its upstream end has been found to ensure that the filter segment is not damaged during the capsule activation process, thereby not adversely affecting the performance of the inhaler article and the consumer experience.

[0024] In this specification, the expression "without substantial deformation" refers to a filter segment that is not plastically, irreversibly, or permanently deformed.Advantageously, the filter segment is sufficiently rigid and strong to withstand a force of up to about 15 Newtons applied to its upstream end without being plastically, reversibly, or permanently deformed in the longitudinal direction.The permanent deformation remaining in the filter segment after the capsule penetrates may adversely affect the overall performance and structural integrity of the inhaler article.

[0025] The filter segment may be formed of a fibrous material. The filter segment may be formed of a porous material. The filter segment may be formed of a biodegradable material. The filter segment may be formed of a cellulosic material, such as cellulose acetate. The filter segment may be formed of a polylactic acid-based material. The filter segment may be formed of a bioplastic material, preferably a starch-based bioplastic material. The filter segment may be fabricated by injection molding or extrusion. Bioplastic-based materials may include multiple relatively large airflow channels extending through the filter segment material, which is advantageous because they can provide suitable RTD characteristics to ensure proper capsule depletion while also providing filter segment structures that are simple and inexpensive to manufacture with specific and complex cross-sectional profiles sufficient to withstand the forces endured by the filter segment during capsule activation.

[0026] The filter segments may be formed from sheets of suitable material that are crimped, pleated, gathered, woven, or folded into elements that define a plurality of longitudinally extending channels. Such sheets of suitable material may be formed from paper, cardboard, polymers such as polylactic acid, or any other cellulosic, paper, or bioplastic-based material. The cross-sectional profile of such a filter segment may exhibit randomly oriented channels.

[0027] The filter segment may be formed in any other suitable manner. For example, the filter segment may be formed from a bundle of longitudinally extending tubes. The longitudinally extending tubes may be formed from polylactic acid. The filter segment may be formed by extrusion, molding, lamination, injection, or chopping of a suitable material. Therefore, it is preferable that there is a low, non-zero pressure drop (or RTD) from the upstream end of the filter segment to the downstream end of the filter segment.

[0028] The filter segment may include at least one filter (airflow) channel extending along the filter segment. Preferably, the at least one filter airflow channel extends along the entire length of the filter segment. The at least one filter channel may have a substantially circular cross-section. The at least one filter channel may have a substantially Y-shaped or T-shaped cross-section. The filter segment may include multiple such filter airflow channels extending along the filter segment. The filter segment may include at least three filter airflow channels. Providing at least one filter airflow channel within the filter segment allows the filter segment to meet a specific RTD value while not sacrificing the strength of the filter segment to withstand the capsule activation process.

[0029] The ratio of the total cross-sectional area of ​​the at least one filter channel to the total cross-sectional area of ​​the filter segment may be at least 25%. In other words, the open area of ​​the filter segment may be at least 25%. The ratio of the total cross-sectional area of ​​the at least one filter channel to the total cross-sectional area of ​​the filter segment may be at least 50%. The ratio of the total cross-sectional area of ​​the at least one filter channel to the total cross-sectional area of ​​the filter segment may be at least 75%. The ratio of the total cross-sectional area of ​​the at least one filter channel to the total cross-sectional area of ​​the filter segment may be at least 80%. Furthermore, the filter segment itself may be porous. Providing a large proportion of the filter channel, or open area, ensures that the RTD and RTD per unit length of the filter segment are low enough to ensure adequate capsule depletion. Furthermore, this also allows for an appropriately rigid and strong material for the filter segment that can withstand the penetration forces applied to the capsule and filter segment while also providing low RTD characteristics.

[0030] The filter channel of the filter segment is preferably smaller than the diameter of the capsule.Therefore, the width of the filter channel may be less than the diameter of the capsule.This diameter of the capsule refers to the maximum diameter of the capsule.The width of the filter channel may be less than 6 mm, more preferably less than 5.5 mm, and even more preferably less than 5 mm.

[0031] The filter segment may not consist of a hollow tubular segment that defines a single, unobstructed airflow channel between its upstream and downstream ends and has a wall thickness of less than 1 mm. Such a hollow tubular segment may effectively provide an RTD of 0 mm of water and an RTD per unit length. This is too low to provide a pleasant user experience, and the hollow tubular segment may not be capable of retaining a capsule within the cavity during activation and use.

[0032] The Young's modulus (or elastic modulus) of the filter segment material may be greater than or at least about 10 MPa. Unless otherwise specified, the Young's modulus of the filter segment material is measured according to ASTM E111-17. The Young's modulus (or elastic modulus) of the filter segment material may be greater than or at least about 20 MPa. The Young's modulus (or elastic modulus) of the filter segment material may be greater than or at least about 30 MPa. Young's modulus (or elastic modulus) preferably refers to the Young's modulus of the component material along the longitudinal axis or direction of the component.

[0033] A capsule can be defined by having a specific puncture strength (in Newtons). The puncture strength of a capsule refers to the specific penetration or puncture force (in Newtons) that a piercing element or needle must exert on the capsule to penetrate or activate it. Methods for measuring the puncture strength of a capsule are known to those skilled in the art. For example, the puncture strength of a capsule may be measured according to ASTM F1306-16. The piercing element or needle may be 27 gauge (outer diameter = 0.42 mm) to 4 gauge (outer diameter = 5 mm). For example, the puncture strength of a sample capsule may be measured using a 3.2 mm (8 gauge) diameter piercing element or hemispherical probe.

[0034] The filter segment may be configured to withstand, without substantial deformation, a force of at least about 50% of the capsule's puncture strength applied to the upstream end of the filter segment. The filter segment may be configured to withstand, without substantial deformation, a force of up to about 100% of the capsule's puncture strength applied to the upstream end of the filter segment. The filter segment may be configured to withstand, without substantial deformation, a force of up to about 200% of the capsule's puncture strength applied to the upstream end of the filter segment. The filter segment may be configured to withstand, without substantial deformation, a force of at least 50% to about 100% of the capsule's puncture strength applied to the upstream end of the filter segment. The filter segment may be configured to withstand, without substantial deformation, a force of at least 50% to about 200% of the capsule's puncture strength applied to the upstream end of the filter segment.

[0035] The filter segment (or element) may extend from the cavity to the downstream end of the inhaler article, in other words, the length of the downstream section of the inhaler article is the same as the length of the filter segment.

[0036] The length of the filter segment may be greater than about 10 mm, or at least about 10 mm. The length of the filter segment may be greater than about 15 mm, or at least about 15 mm. The length of the filter segment may be greater than about 20 mm, or at least about 20 mm. The length of the filter segment may be less than about 30 mm. The length of the filter segment may be between about 10 mm and 30 mm. The length of the filter segment may be between about 10 mm and about 20 mm.

[0037] The filter segment may preferably be about 15 mm to 20 mm in length. The length of the filter segment may be about 17 mm.

[0038] The inhaler article may have an outer diameter within the range of about 6 mm to about 10 mm, or about 7 mm to about 10 mm, or about 7 mm to about 9 mm, or about 7 mm to about 8 mm, or about 7.2 mm. The inhaler article may have a length (along its longitudinal axis) within the range of about 40 mm to about 100 mm, or about 40 mm to about 80 mm, or about 40 mm to about 60 mm. Preferably, the length of the inhaler article is about 45 mm. The length of the inhaler article is preferably selected so that the mouthpiece end of the inhaler article protrudes from the holder of the inhaler system, which is described in more detail below.

[0039] The (distal, front or upstream) end plug may extend from the upstream end of the inhaler article into the cavity.

[0040] The end plug may define at least one air flow inlet channel (or air intake port) extending from the upstream end of the inhaler article, or the end plug, to the cavity so that fluid communication is established between the cavity and the exterior of the inhaler article.

[0041] The end plug may define a central through channel extending from the distal end of the inhaler article toward the capsule cavity. The end plug may include a central channel extending through the body of the end plug. The central channel may be configured to provide a piercing element with access to the cavity, as described in the present disclosure. The through central channel of the end plug may be coaxial with the longitudinal axis of the inhaler article. The linear through channel may be sized to allow the piercing element to pass through the linear through channel.

[0042] The end plugs may include resealable elements disposed on or within the central channel. Resealable elements, such as septa or resealable membranes, may be disposed at either end of the central through channel.

[0043] Advantageously, the provision of a through channel along the end plug allows for reliable penetration of the capsule contained within the capsule cavity, and the resealable element maintains the integrity of the desired airflow pattern within the capsule cavity.

[0044] The resealable element may seal the central channel. The resealable element may form a hermetic or airtight seal or barrier along the central channel. The central channel may be formed of a pierceable material. A piercing element may pass through the resealable element to puncture the capsule within the capsule cavity. The resealable element may reseal when the piercing element is retracted or removed from the resealable element. The resealable element or membrane may include a septum or septum-like element. The resealable element or membrane may be formed of an elastic material such as rubber, silicone, metal foil co-laminated with a polymer, or latex, and the like.

[0045] The end plug may include at least one air inlet channel that allows air to enter the cavity of the inhaler article.

[0046] At least one air flow inlet channel may extend in a direction tangential to the central channel. In such embodiments, air may enter the central channel through the side of the inhaler article. However, in the present disclosure, it is preferred that the air flow inlet channel extend along the body of the end plug in a direction non-parallel to the longitudinal axis of the inhaler article.

[0047] At least one air flow inlet channel may extend from the distal end or distal end face of the end plug to the inner end or inner end face of the end plug. The air flow inlet channel may extend the length of the end plug body. The air flow inlet channel may extend from the distal end or distal end face of the end plug to the inner end or inner end face of the end plug and define a curved, helical, spiral, or arcuate path. The air flow inlet channel may extend from the distal end or distal end face of the end plug to the inner end or inner end face of the end cap and define a curved, helical, spiral, or arcuate path along the outer surface of the end plug body. The at least one air flow inlet channel may extend both longitudinally along the end plug and circumferentially around the end plug. In other words, the at least one air flow inlet channel may extend in a direction non-parallel to the longitudinal axes of the inhaler article and the end plug. Thus, the at least one air flow inlet channel may follow a spiral, helical, arcuate or curved profile along the outer surface of the end plug body.

[0048] The curved, helical, spiral, or arcuate air inlet channel can be configured to induce a swirling airflow pattern within the capsule cavity of the inhaler article. The air inlet channel can draw inlet air from the end plug distal end into the capsule cavity of the inhaler article. The air inlet channel can induce a rotating or swirling airflow as the air flows through the air inlet channel and through the capsule cavity. Airflow through the inhaler article preferably enters the inhaler article at the distal end face or end plug distal end of the inhaler article and travels in a swirling airflow pattern along the longitudinal axis of the inhaler article to the mouth end or downstream end. The entrance of the airflow channel can be defined within the end plug distal end face. The end plug distal end face can be perpendicular to the longitudinal axis of the inhaler article.

[0049] The air inlet channel may be continuously non-parallel to the longitudinal axis of the inhaler article along the entire length of the air inlet channel. The air inlet channel may be parallel along a portion of the length of the air inlet channel and non-parallel along the remainder of the length of the air inlet channel. The air inlet channel may be parallel to a first or upstream portion of the air inlet channel and non-parallel to a second or downstream portion of the air inlet channel that exits into the capsule cavity. The second portion may define about 50% or less of the entire length of the air inlet channel, or between about 5% and about 50%, or between about 10% and about 30%.

[0050] The end plug may be inserted into the distal end of the inhaler article, may be secured to the inhaler article by a friction or interference fit, or may be secured within the inhaler article. A distal end portion of the inhaler article, such as a hollow tubular element (described below), may cooperate with the end plug air inlet channel to enclose the air inlet channel or form the remainder of the air inlet channel.

[0051] The air inlet channel may extend a distance along an arc coaxial with the longitudinal axis. The air inlet channel may be curved relative to the longitudinal axis of the inhaler article. The air inlet channel may rotate around the circumference of the end plug as a function of position along the length of the end plug. The air inlet channel may rotate around about 5% to about 100%, or about 25% to about 50% of the circumference of the end plug. The air inlet channel may rotate around the circumference of the arc length of the end plug (the distance as viewed from the distal end face of the end plug) with a central angle (which may coincide with the longitudinal axis of the inhaler article) within the range of about 5 degrees to about 360 degrees, or about 45 degrees to about 180 degrees, or about 45 degrees to about 135 degrees.

[0052] The air inlet channel may enter the capsule cavity at an angle relative to the longitudinal axis. The air inlet channel may enter the capsule cavity at an angle in the range of about 5 degrees to about 89 degrees, or about 45 degrees to about 89 degrees, or about 60 degrees to about 89 degrees, or about 70 degrees to about 88 degrees. The air inlet channel may have a first portion parallel to the longitudinal axis and a second portion exiting into the capsule cavity at an angle relative to the longitudinal axis, as described above.

[0053] The end plug may include at least two, or more than two, air inlet channels formed within the end plug body. The end plug may include at least three, or more than three, air inlet channels formed within the end plug body. The air inlet channels may be symmetrically positioned around the end plug. The air inlet channels may oppose each other around the end plug along the length of the end plug. One or more air inlet channels may have a helical shape (forming a portion of a spiral). The helical air inlet channels may be symmetrically positioned along the length of the end plug, and preferably oppose each other along the length of the end plug. The air inlet channels may each extend a distance along an arc that is each coaxial with the longitudinal axis.

[0054] The at least one air flow inlet channel (or air inlet) may include two air flow inlet channels configured to generate a swirling airflow within the cavity. This swirling or swirling airflow is delivered to the capsule cavity of the inhaler article. The swirling or swirling airflow induces the capsule contained within the capsule cavity to rotate and release inhalable material particles into the swirling or swirling airflow, which is directed downstream through the filter segment and toward the consumer.

[0055] The end plug and the air inlet channel(s) defined therein can be precisely designed and manufactured to impart a desired airflow pattern through the capsule cavity of the inhaler article.

[0056] The body of the inhaler article, or "inhaler article", may have any suitable shape. The body of the inhaler article, or "inhaler article", may resemble a smoking article or a conventional cigarette in size and shape. The inhaler article may have a substantially uniform outer diameter along the length of the inhaler article. The inhaler article may have a substantially uniform inner diameter along the length of the inhaler article. The inhaler article may have any suitable transverse cross-sectional shape. For example, the transverse cross-section may be circular, oval, square, or rectangular. The inhaler article preferably has a circular cross-section, which may be uniform along the length of the inhaler article, forming an elongated cylindrical body.

[0057] The inhaler article may include a hollow tubular element extending from the upstream end of the inhaler article to the filter segment, such that the end plug and capsule can be positioned within the hollow tubular element. The hollow tubular element may be formed of a polymeric or cellulosic material, or any other suitable material. The inhaler article may be formed of a biodegradable material. The inhaler article is preferably formed of cardboard or heavy paper. The hollow tubular element may have a uniform thickness along its length. The hollow tubular element may have a thickness ranging from about 1 mm to about 2 mm.

[0058] The end plug may include a collar portion having a larger diameter than the remainder of the body of the end plug. The collar portion may function as a physical stop to ensure proper placement of the end plug within the distal end portion of the hollow tubular element. The collar portion may abut against the elongate inhaler article. The collar portion may have a diameter that is about 0.5 mm to about 1 mm larger than the diameter of the remainder of the body of the end plug. The collar portion may have a diameter that is substantially similar to or the same as the outer diameter of the hollow tubular element or the inhaler article.

[0059] The inhaler article may include a filter wrapper surrounding the filter segment of the downstream section. The inhaler article may include a packaging material or inhaler article wrapper surrounding the hollow tubular element and the downstream section. The packaging material may secure the downstream section in axial alignment with the end plug. The packaging material may be formed from a biodegradable material. The packaging material may be formed from a paper wrapper.

[0060] The end plugs may have a length in the range of about 3 mm to about 12 mm, or about 4 mm to about 10 mm, or about 5 mm to about 9 mm, or about 8 mm. The end plugs may have an outer diameter sufficient to form an interference or friction fit with the inner diameter of the hollow tubular element. The end plugs may have an outer diameter in the range of about 5 mm to about 10 mm, or about 6 mm to about 9 mm, or about 6.5 mm to about 8.5 mm, or about 7.5 mm. The length of the central channel may be equal to the length of the end plugs.

[0061] The end plug may be disposed at the distal end of the body. The end plug may define the distal end of the inhaler article. Preferably, at least one air inlet port of the end plug is proximate the distal or upstream end of the inhaler article. The central channel may include a first end defining the upstream boundary of the capsule cavity and a second, opposite end defining the distal end of the inhaler article body. Preferably, the second, opposite end defines the open distal end of the inhaler article body. The central channel may extend along the longitudinal axis of the inhaler article and may define an opening at the distal end of the inhaler article that is coaxial with the longitudinal axis of the inhaler article.

[0062] Advantageously, the end plug may include an open opening along the longitudinal axis and may have no element blocking or obstructing the open distal end of the inhaler article to reduce the complexity of the inhaler article: after the capsule has been pierced, the consumer may simply block or obstruct the open distal end with the holder or the consumer's finger to direct the inhalation airflow substantially through the air inlet on the inhaler article.

[0063] The end plugs are preferably formed from a biodegradable material. The end plugs preferably comprise a fibrous material. The end plugs are preferably formed from a porous material. The end plugs are preferably formed from a cellulosic material, such as cellulose acetate. The end plugs are preferably formed from a polylactic acid material. Advantageously, the end plugs may be formed from materials used to construct conventional cigarettes. Advantageously, the inhaler article may be formed from a biodegradable material.

[0064] Air flow through the inhaler article preferably enters the inhaler article through the upstream end of the inhaler article via an air flow inlet channel, then flows along the longitudinal axis of the inhaler article, through the capsule cavity and filter segment, and exits at the mouthpiece or downstream end of the inhaler article.

[0065] The central channel may have a uniform inner or open diameter extending from the capsule cavity to the open distal or most upstream end of the inhaler article. The central channel may have a diameter that is at least about 50%, or at least about 70%, or at least about 75% of the diameter of the inhaler article. The central channel may have a diameter in the range of about 3 mm to about 6.5 mm, or about 4 mm to about 6 mm, or about 5 mm to about 6 mm, or about 5.5 mm. Alternatively, the central channel may have a diameter in the range of about 0.5 mm to about 2 mm.

[0066] The capsule is preferably retained within the capsule cavity. The central channel may have a uniform diameter extending from the capsule cavity to the open distal or most upstream end of the inhaler article or end plug. The central channel may have a diameter that is at least about 50%, or at least about 70%, or at least about 75% of the diameter of the distal end of the body. The central channel of the end plug may have a diameter within a range of about 50% to about 90% of the diameter of the capsule retained within the capsule cavity. This sizing of the central channel ensures that the capsule will not be removed from the inhaler article through the central channel of the end plug.

[0067] As described above, as air flows through the air flow inlet channel in the end plug and through the capsule cavity, it may induce a rotational or swirling airflow. Advantageously, this swirling airflow generated by the air flow inlet channel in the end plug is useful for efficient depletion of the capsule during consumption after it has been pierced. Advantageously, this "swirling" effect may cause agitation or rotation of the capsule to provide uniform entrainment of a portion or fraction of the nicotine particles from the capsule over two or more, five or more, or ten or more inhalations or "puffs" by the user.

[0068] The inhalable material may include nicotine. Preferably, the capsule contains pharmaceutically active particles. The pharmaceutically active particles may include nicotine. The pharmaceutically active particles may have a mass median aerodynamic diameter of about 5 micrometers or less, or in the range of about 0.5 micrometers to about 4 micrometers, or in the range of about 1 micrometer to about 3 micrometers.

[0069] Advantageously, the inhaler article efficiently delivers nicotine particles to the lungs at an inhalation dose or airflow rate that is within the range of that of traditional smoking. The inhaler delivers the nicotine article in an inhaler article having a configuration similar to that of a traditional cigarette. The inhaler article or system described herein may deliver dry powder to the lungs at an inhalation dose or airflow rate that is within the range of that of traditional smoking. The consumer may take multiple inhalations or "puffs," with each "puff" delivering a portion of the dry powder contained within the capsule contained within the capsule cavity. The inhaler article may have a configuration similar to that of a traditional cigarette and may mimic the traditional smoking technique. The inhaler article may be simple to manufacture and convenient for the consumer to use.

[0070] Airflow management through the capsule cavity of the inhaler article may cause the capsule contained therein to rotate during inhalation and consumption. The capsule may contain nicotine-containing particles (also referred to as "nicotine powder" or "nicotine particles") and, optionally, flavor-containing particles (also referred to as "flavor particles"). Rotation of the pierced capsule may suspend and aerosolize the nicotine particles released from the pierced capsule into the inhaled air traveling through the inhaler article. The flavor particles may be larger than the nicotine particles and help deliver the nicotine particles to the user's lungs, while the flavor particles preferentially remain in the user's mouth or oral cavity. The nicotine particles and optional flavor particles may be delivered by the inhaler article at an inhalation volume or airflow rate within the range of that of conventional smoking.

[0071] The term "nicotine" refers to nicotine and nicotine derivatives (eg, free base nicotine, nicotine salts, and the like).

[0072] The term "flavorant" or "flavor" refers to an organoleptic compound, composition, or material that alters, or is intended to alter, the taste or aroma characteristics of nicotine during its consumption or inhalation.

[0073] According to another aspect of the present disclosure, there is provided an inhaler system comprising an inhaler article as described herein and a holder for receiving the inhaler article, the holder including a housing defining a housing cavity configured to receive the inhaler article, the holder including a piercing element extending into the housing cavity and configured to pierce a capsule of the inhaler article.

[0074] The holder may include a piercing element extending into the housing cavity configured to pierce the capsule of the inhaler article.

[0075] A holder for an inhaler article may be combined with an inhaler article (described herein) that contains a capsule for activating the inhaler article by piercing the capsule, provides reliable activation of the capsule within the inhaler article (by piercing the capsule with a piercing element in the holder), and releases particles contained within the capsule, allowing the article to deliver the particles to a consumer. Although the holder is separate from the inhaler article, a consumer may utilize both the inhaler article and the holder while consuming the particles released within the inhaler article. A plurality of these inhaler articles may be combined with a holder to form a system or kit. A single holder may be utilized with 10 or more, or 25 or more, or 50 or more, or 100 or more inhaler articles to activate (puncture or pierce) the capsule contained within each inhaler article and provide reliable activation or, optionally, a visual indication (marking) of inhaler article activation for each inhaler article.

[0076] The inhaler article holder includes a housing having a housing cavity for receiving the inhaler article and a sleeve configured to hold the inhaler article within the housing cavity. The sleeve has a sleeve cavity and is movable within the housing cavity along the longitudinal axis of the housing. The sleeve has a first open end and a second opposite end. The first open end is configured to receive the distal end of the inhaler article. The second opposite end of the sleeve is configured to contact the distal end of the inhaler article. The second opposite end of the sleeve is configured to direct substantially all inhaled air to flow through the inhaler article via at least one air inlet extending in a direction non-parallel to the central channel.

[0077] The inhaler system includes an inhaler article described herein having a capsule disposed within the capsule cavity, and a holder for receiving the inhaler article. The holder includes a housing having a housing cavity for receiving the inhaler article and a sleeve configured to hold the inhaler article within the housing cavity. The sleeve includes a sleeve cavity, and the sleeve is movable within the housing cavity along the longitudinal axis of the housing. The sleeve includes a first open end and a second opposite end. The first open end is configured to receive the inhaler article, and the second opposite end of the sleeve is configured to contact the distal end of the inhaler article.

[0078] The method, as described herein, includes inserting an inhaler article into the sleeve of the inhaler article holder until the distal end of the inhaler article contacts the second, opposite end of the sleeve. The inhaler article includes a body (extending from the mouthpiece end to the distal end along the inhaler longitudinal axis), a length of the body, and a capsule disposed within the inhaler article body. The inhaler article and sleeve are then moved toward the piercing element until the piercing element penetrates the capsule. Air is then drawn into the second, opposite end of the holder sleeve to form a rotating or swirling airflow through the cavity of the inhaler article, directing the inhalation airflow into an air inlet on the inhaler article. This swirling inhalation airflow is directed into the capsule cavity while the inhaler article is disposed within the inhaler article holder. The consumed inhaler article may then be removed from the holder and disposed of. An unused inhaler article may then be inserted into the holder, and the method may be repeated.

[0079] The inhaler articles described herein may be combined with a piercing element or a holder containing a piercing element to deliver nicotine particles from the capsule to the user. The piercing element or piercing device (or holder) may be separate from or not form part of the inhaler article. Multiple inhaler articles may be combined with a piercing element or piercing device (or holder) to form a kit.

[0080] The holder includes a housing having a housing cavity for receiving the inhaler article and a sleeve configured to hold the inhaler article within the housing cavity. The sleeve includes the sleeve cavity, and the sleeve is movable within the housing cavity along the longitudinal axis of the housing. The sleeve includes a first open end and a second opposite end. The first open end is configured to receive the inhaler article, and the second opposite end of the sleeve is configured to contact the distal end of the inhaler article.

[0081] A second, opposite end of the sleeve is preferably configured to direct substantially all of the inhaled air to flow through at least one air inlet port of the inhaler article that extends in a direction non-parallel to the central channel.

[0082] Advantageously, the holder may cooperate with the inhaler article to direct substantially all of the inhalation air flow through the air inlet opening of the end plug of the inhaler article.

[0083] Preferably, the holder further includes a piercing element secured to and extending from the inner surface of the housing, the piercing element extending through the second opposite end of the sleeve and configured to extend into the capsule cavity to penetrate the capsule along the longitudinal axis of the housing.

[0084] The capsule may be sealed within the inhaler article prior to consumption. For transport and storage, the inhaler article may be contained in a sealed or airtight container or bag. The inhaler article may include one or more peelable sealing layers for covering one or more air inlet channels at the distal end of the inhaler article or the air outlet at the mouthpiece end of the inhaler article. This may ensure that the inhaler article maintains proper hygiene and freshness, or may prevent the capsule from drying out, becoming hard, and becoming brittle.

[0085] The capsule may rotate about its longitudinal or central axis as air is drawn through the inhaler article. The capsule may be formed of an airtight material that substantially contains the particles within the capsule interior. The capsule may be configured to be pierced or perforated by a piercing element when within the capsule cavity. The piercing element may be separate from or combined with the inhaler article. The capsule may be formed of any suitable material. The capsule may be formed of a metallic or polymeric material that functions to keep contaminants out of the capsule but can be pierced or perforated by a piercing element prior to consumption to allow release of nicotine particles from within the capsule. The capsule may be formed of a polymeric material. The polymeric material may be hydroxypropyl methylcellulose (HPMC). The capsule may be any suitable size. The capsule may be a size 1 to size 4 capsule, or a size 3 capsule, or a size 3 capsule.

[0086] The system may include a separate piercing element, such as a metal or rigid needle, that forms a single opening through the capsule received within the capsule cavity. The piercing element may be configured to pass through the end plug, or more precisely, its central piercing channel, and into the capsule cavity.

[0087] A holder for an inhaler article may be combined with an inhaler article (described herein) that contains a capsule for activating the inhaler article by piercing the capsule, provides reliable activation of the capsule within the inhaler article (by piercing the capsule with a piercing element in the holder), and releases particles contained within the capsule, allowing the article to deliver the particles to a consumer. Although the holder is separate from the inhaler article, a consumer may utilize both the inhaler article and the holder while consuming the particles released within the inhaler article. A plurality of these inhaler articles may be combined with a holder to form a system or kit. A single holder may be utilized with 10 or more, or 25 or more, or 50 or more, or 100 or more inhaler articles to activate (puncture or pierce) the capsule contained within each inhaler article and provide reliable activation or, optionally, a visual indication (marking) of inhaler article activation for each inhaler article.

[0088] The inhaler article holder includes a housing having a housing cavity for receiving the inhaler article and a sleeve configured to hold the inhaler article within the housing cavity. The sleeve has a sleeve cavity and is movable within the housing cavity along the longitudinal axis of the housing. The sleeve has a first open end and a second opposite end. The first open end is configured to receive the distal or upstream end of the inhaler article. The second opposite end of the sleeve is configured to contact the distal end of the inhaler article. The second opposite end of the sleeve is configured to direct substantially all inhaled air to flow through at least one air inlet of the inhaler article, which extends in a direction non-parallel to the central channel of the end plug.

[0089] An inhaler system may include an inhaler article described herein having a capsule disposed within the capsule cavity, and a holder for receiving the inhaler article. The holder includes a housing having a housing cavity for receiving the inhaler article and a sleeve configured to hold the inhaler article within the housing cavity. The sleeve includes a sleeve cavity, and the sleeve is movable within the housing cavity along the longitudinal axis of the housing. The sleeve includes a first open end and a second opposite end. The first open end is configured to receive the inhaler article, and the second opposite end of the sleeve is configured to contact the distal end of the inhaler article.

[0090] The holder may further include a piercing element secured to and extending from the inner surface of the housing, the piercing element extending through the second opposite end of the sleeve and configured to extend into the capsule cavity to pierce the capsule along the longitudinal axis of the housing.

[0091] The holder may further include a spring element configured to bias the sleeve toward the open proximal end of the housing and between a relaxed position and a compressed position. The spring element may be contained within the housing cavity (also referred to as the inhaler article cavity) of the holder and may be compressed as the movable sleeve and inhaler article move toward the piercing element. The spring element may be located between the sleeve and the distal end of the housing, or may contact the sleeve and the distal end of the housing. The spring element may be between the distal end of the sleeve and the distal end of the housing. The spring element may contact the distal end of the sleeve and the distal end of the housing. The spring element may be disposed around the piercing element. The spring element may be coaxial with the piercing element. The spring element may be a conical spring.

[0092] The spring element biases the inhaler article away from the piercing element. During use, a user may insert the inhaler article into the inhaler article cavity of the holder. By doing so, the spring may be compressed, allowing the inhaler article to move toward the distal end of the inhaler article cavity. Eventually, the piercing element may penetrate a capsule disposed within the inhaler article. Once penetration occurs, the user may release the inhaler article, allowing the spring to bias the inhaler article toward the proximal end of the inhaler article cavity and away from the piercing element. The user may then inhale the proximal end of the inhaler article.

[0093] The sleeve may define a first air inlet zone comprising at least one air opening through the sleeve. The first air inlet zone is proximate the proximal end of the sleeve. The first air inlet zone is configured to allow air to flow from an interior of the sleeve to an air flow channel formed between the sleeve and the housing inner surface. The sleeve may include a second air inlet zone comprising at least one air opening through the sleeve. The second air inlet zone is proximate the distal end of the sleeve. The second air inlet zone is configured to allow air to flow from the air flow channel to an interior of the sleeve.

[0094] The holder may include a marking element extending into the housing (or inhaler article) cavity. The marking element may be configured to mark the surface of the inhaler article. The marking element may extend perpendicular to the longitudinal axis of the holder and the inhaler article. The marking element may be configured to mechanically mark the outer surface of the inhaler article. For example, the marking element may be configured to scrape, cut, abrade, imprint, fold, or curve the outer surface of the inhaler article. The marking element may have a sharp edge configured to scratch the outer surface of the inhaler article when received within the housing cavity. The marking element may color the outer surface of the inhaler article when received within the housing cavity. The marking element may mark the outer surface of the inhaler article when the piercing element penetrates a capsule disposed within the inhaler article, thus indicating that the inhaler article has been activated and may be consumed by the user. Advantageously, this may also prevent a user from attempting to reuse a previously activated inhaler article.

[0095] The marking element may extend perpendicular to the longitudinal axis of the holder and inhaler article. The marking element may be formed from a rigid material configured to provide a visual indication that the marking element has contacted the outer surface of the inhaler. The marking element may be fixed to the holder housing. The marking element may form an alignment pin, as described above.

[0096] The marking element may extend through at least a portion of the thickness of the holder. The marking element may extend through the sleeve. The marking element may extend into the housing cavity and into the sleeve. The marking element may extend at least a marking distance beyond the sleeve such that the marking element contacts the inhaler outer surface when the inhaler article is received within the housing cavity. The marking element may be aligned with and mate with an elongated slot in the sleeve.

[0097] The capsule may contain nicotine (also referred to as "nicotine powder" or "nicotine particles") and, optionally, pharmaceutically active particles, including flavor-containing particles (also referred to as "flavor particles"). The capsule may contain a predetermined amount of nicotine particles and, optionally, flavor particles. The capsule may contain sufficient nicotine particles to provide at least two inhalations or "puffs," or at least about five inhalations or "puffs," or at least about 10 inhalations or "puffs." The capsule may contain sufficient nicotine particles to provide about 5-50 inhalations or "puffs," or about 10-30 inhalations or "puffs." Each inhalation or "puff" may deliver about 0.1 mg to about 3 mg of nicotine particles to the user's lungs, or about 0.2 mg to about 2 mg of nicotine particles to the user's lungs, or about 1 mg of nicotine particles to the user's lungs.

[0098] The nicotine particles may have any useful concentration of nicotine based on the particular formulation employed. The nicotine particles may have at least about 1% up to about 30% by weight nicotine, or about 2% to about 25% by weight nicotine, or about 3% to about 20% by weight nicotine, or about 4% to about 15% by weight nicotine, or about 5% to about 13% by weight nicotine. Preferably, with each inhalation or "puff," about 50 to about 150 micrograms of nicotine may be delivered to the user's lungs.

[0099] The capsule may hold or contain at least about 5 mg of nicotine particles, or at least about 10 mg of nicotine particles. The capsule may hold or contain less than about 900 mg of nicotine particles, or less than about 300 mg of nicotine particles, or less than 150 mg of nicotine particles. The capsule may hold or contain between about 5 mg and about 300 mg of nicotine particles, or between about 10 mg and about 200 mg of nicotine particles.

[0100] When flavor particles are blended or combined with nicotine particles in a capsule, the flavor particles may be present in an amount that provides the desired flavor with each inhalation or "puff" delivered to the user.

[0101] The nicotine particles may have any size distribution useful for inhalation delivery preferentially into the lungs of the user. The capsule may contain particles other than nicotine particles. The nicotine particles and other particles may form a powder system.

[0102] A capsule may hold or contain at least about 5 mg of dry powder (also called a powder system), or at least about 10 mg of dry powder. A capsule may hold or contain less than about 900 mg of dry powder, or less than about 300 mg of dry powder, or less than about 150 mg of dry powder. A capsule may hold or contain between about 5 mg and about 300 mg of dry powder, or between about 10 mg and about 200 mg of dry powder, or between about 25 mg and about 100 mg of dry powder.

[0103] The dry powder or powder system may have at least about 40% by weight, or at least about 60% by weight, or at least about 80% by weight of the powder system consisting of nicotine particles with a particle size of about 5 micrometers or less, or in the range of about 1 micrometer to about 5 micrometers.

[0104] The nicotine-containing particles may have a mass median aerodynamic diameter of about 5 micrometers or less, or in the range of about 0.5 micrometers to about 4 micrometers, or in the range of about 1 micrometer to about 3 micrometers, or in the range of about 1.5 micrometers to about 2.5 micrometers, preferably as measured by a cascade impactor.

[0105] The flavor-containing particles may have a mass median aerodynamic diameter of about 20 micrometers or more, or about 50 micrometers or more, or in the range of about 50 to about 200 micrometers, or in the range of about 50 to about 150 micrometers, preferably as measured by a cascade impactor.

[0106] The dry powder may have a median particle size of about 60 micrometers or less, or in the range of about 1 micrometer to about 40 micrometers, or in the range of about 1.5 micrometers to about 25 micrometers, where median particle size refers to the median particle size per mass and is preferably measured by laser diffraction, laser diffusion, or electron microscopy.

[0107] The nicotine in the powder system or nicotine particles can be pharmaceutically acceptable free base nicotine, or nicotine salt or nicotine salt hydrate.Useful nicotine salt or nicotine salt hydrate includes, for example, nicotine pyruvate, nicotine citrate, nicotine aspartate, nicotine lactate, nicotine bitartrate, nicotine salicylate, nicotine fumarate, nicotine mono-pyruvate, nicotine glutamate, or nicotine hydrochloride.The compound that combines with nicotine to form a salt or salt hydrate can be selected based on its expected pharmacological effect.

[0108] Preferably, the nicotine particles contain an amino acid. Preferably, the amino acid may be leucine, such as L-leucine. Providing an amino acid, such as L-leucine, to nicotine-containing particles may reduce the adhesive force of the nicotine-containing particles, and may also reduce the attractive force between nicotine particles, thereby reducing the aggregation of the nicotine particles. Similarly, it may also reduce the adhesive force to flavor-containing particles, thereby reducing the aggregation of nicotine particles with flavor particles. Therefore, the powder system described herein may be a free-flowing material, and may have a stable relative particle size of each powder component even when nicotine particles and flavor particles are combined.

[0109] Preferably, the nicotine may be a surface-modified nicotine salt, in which case the nicotine salt particles include coated particles or composite particles. A preferred coating or composite material may be L-leucine. One particularly useful nicotine particle may be nicotine bitartrate with L-leucine.

[0110] The powder system may comprise a population of flavor particles, which may have any size distribution useful for selective inhalation delivery to the mouth or oral cavity of a user.

[0111] The powder system may have at least about 40% by weight, or at least about 60% by weight, or at least about 80% by weight of the powder system's flavor particle population consisting of particles with a particle size of about 20 micrometers or greater. The powder system may have at least about 40% by weight, or at least about 60% by weight, or at least about 80% by weight of the powder system's flavor particle population consisting of particles with a particle size of about 50 micrometers or greater. The powder system may have at least about 40% by weight, or at least about 60% by weight, or at least about 80% by weight of the powder system's flavor particle population consisting of particles with a particle size in the range of about 50 micrometers to about 150 micrometers.

[0112] The flavor-containing particles may include a compound for reducing adhesion or surface energy and the resulting aggregation. The flavor particles may be surface-modified with an adhesion-reducing compound to form coated flavor particles. One preferred adhesion-reducing compound may be magnesium stearate. Providing flavor particles, particularly coating the flavor particles, with an adhesion-reducing compound such as magnesium stearate may reduce the adhesion of the flavor-containing particles and may also reduce the attractive forces between the flavor particles, thereby reducing the aggregation of the flavor particles. Therefore, it may also reduce the aggregation of flavor particles with nicotine particles. Therefore, the powder system described herein may have a stable relative particle size of the nicotine-containing particles and the flavor-containing particles, even when the nicotine particles and the flavor particles are combined. Preferably, the powder system may be free-flowing.

[0113] Conventional formulations for dry powder inhalation contain carrier particles that function to increase the fluidization of active particles, because the active particles may be too small to be affected by simple airflow through the inhaler.Powder systems can contain carrier particles.These carrier particles can be saccharides such as lactose or mannitol, which can have a particle size of more than about 50 micrometers.Carrier particles can be used in formulations to improve dose uniformity by acting as a diluent or bulking agent.

[0114] Powder systems utilized with the nicotine powder delivery systems described herein may be carrier-free or substantially free of saccharides such as lactose or mannitol, which may allow the nicotine to be inhaled and delivered to the user's lungs at an inhalation volume or airflow rate similar to that of a typical smoking session.

[0115] The nicotine particles and flavors can be combined in a single capsule. As mentioned above, the nicotine particles and flavors can each have a reduced adhesive force, which results in a stable particle formulation, in which the particle size of each component does not change substantially when the nicotine-containing particles and flavor-containing particles are combined. Alternatively, the powder system can include nicotine particles contained in a single capsule and flavor particles contained in a second capsule.

[0116] The nicotine particles and flavor particles can be combined in any useful relative amounts such that the flavor particles are detectable by a user when consumed along with the nicotine particles. Preferably, the nicotine particles and flavor particles form at least about 90% by weight, or at least about 95% by weight, or at least about 99% by weight, or 100% by weight of the total weight of the powder system.

[0117] The inhaler and inhaler system are less complex and have a simplified airflow path compared to conventional dry powder inhalers. Advantageously, the rotation of the capsule within the inhaler article may aerosolize the nicotine particles or powder system and help maintain a free-flowing powder. Therefore, the inhaler article may not require the high inhalation dose typically utilized by conventional inhalers to deliver the nicotine particles deep into the lungs.

[0118] The inhaler article may use a flow rate of less than about 5 L / min, or less than about 3 L / min, or less than about 2 L / min, or less than about 1.6 L / min. Preferably, the flow rate may be in the range of about 1 L / min to about 3 L / min, or about 1.5 L / min to about 2.5 L / min. Preferably, the inhalation volume or flow rate may be similar to the Health Canada smoking method flow rate, i.e., about 1.6 L / min.

[0119] The inhaler system may be used by a consumer similar to smoking a traditional cigarette or vaping an e-cigarette. Such smoking or vaping may be characterized by two steps: during the first step, a small volume containing the total amount of nicotine desired by the consumer is drawn into the oral cavity, followed by a second step, in which this small volume containing an aerosol containing the desired amount of nicotine is further diluted with fresh air and drawn deeper into the lungs. Both steps are controlled by the consumer. During the first inhalation step, the consumer may determine the amount of nicotine to be inhaled. During the second step, the consumer may determine the amount to be diluted from the first volume and drawn deeper into the lungs to maximize the concentration of active agent delivered to the epithelial surface of the airways. This smoking mechanism is sometimes referred to as "puff-inhale-exhale."

[0120] The dry powder utilized in the dry powder inhalers of the present disclosure may eliminate or substantially reduce any exhalation of pharmaceutically active particles during the "exhalation" phase. Preferably, substantially all, or at least about 99%, or at least about 95%, or at least 90% of the pharmaceutically active particles have a particle size that is delivered to the lungs but is not small enough to be exhaled normally by breathing. The pharmaceutically active particle size may be within the range of about 0.75 micrometers to about 5 micrometers, or 0.8 micrometers to about 3 micrometers, or 0.8 micrometers to about 2 micrometers.

[0121] The following provides a non-exhaustive list of non-limiting examples, any one or more features of which may be combined with any one or more features of another example, embodiment, or aspect described herein.

[0122] Example 1: an inhaler article having an upstream end and a downstream end, the inhaler article comprising: an upstream section including an end plug; a downstream section located downstream of the upstream section and separated from the upstream section by a gap, the downstream section including a filter segment, a mouthpiece segment, a support segment, a downstream segment, or a retaining segment, wherein the filter segment, mouthpiece segment, support segment, downstream segment, or retaining segment has a withdrawal resistance per unit length greater than 0 millimeters of water column per millimeter and less than 3 millimeters of water column per millimeter; a cavity defined between the upstream section and the downstream section, the cavity configured to be in fluid communication with the exterior of the inhaler article; and a capsule containing an inhalable material, the capsule containing the inhalable material and located within the cavity. Example 2: An inhaler article according to example 1, wherein the resistance to withdrawal per unit length of the filter segment, mouthpiece segment, support segment, downstream segment, or retention segment is greater than 0 millimeters of water column per millimeter and less than 1 millimeter of water column per millimeter. Example 3: An inhaler article according to Example 1 or 2, wherein the filter segment, mouthpiece segment, support segment, downstream segment, or retention segment is configured to withstand a force of up to 15 Newtons applied to its upstream end without substantial deformation. Example 4: An inhaler article according to any of Examples 1 to 3, wherein the Young's modulus of the material of the filter segment, mouthpiece segment, support segment, downstream segment, or retention segment is greater than or at least 10 MPa. Example 5: An inhaler article according to any of Examples 1-4, wherein the resistance to withdrawal of the filter segment, mouthpiece segment, support segment, downstream segment, or retention segment is greater than 0 millimeters of water column and less than 10 millimeters of water column. Example 6: The inhaler article according to any of Examples 1 to 5, wherein the length of the filter segment, mouthpiece segment, support segment, downstream segment, or retention segment is between 10 millimeters and 20 millimeters. Example 7: An inhaler article according to any of Examples 1-6, wherein the filter segment, mouthpiece segment, support segment, downstream segment, or retention segment extends from the cavity to the downstream end of the inhaler article. Example 8: An inhaler article according to any of Examples 1-7, further comprising a hollow tubular element extending from the upstream end of the inhaler article to the filter segment, the mouthpiece segment, the support segment, the downstream segment, or the retainer segment, wherein the end plug and capsule are located within the hollow tubular element. Example 9: An inhaler article according to example 8, wherein the inhaler article comprises a wrapping material surrounding the hollow tubular element and the downstream section, the wrapping material fixing the downstream section in axial alignment with the hollow tubular element. Example 10: An inhaler article according to any of Examples 1-9, wherein the end plug defines at least one air flow inlet channel extending from the upstream end of the end plug to the cavity such that fluid communication is established between the cavity and the exterior of the inhaler article. Example 11: An inhaler article according to example 10, wherein the at least one air flow inlet channel comprises two air flow inlet channels configured to generate a swirling air flow within the cavity. Example 12: An inhaler article according to any of Examples 1-11, wherein the filter segment, mouthpiece segment, support segment, downstream segment, or retaining segment comprises at least one filtered airflow channel extending along the filter segment, mouthpiece segment, support segment, downstream segment, or retaining segment. Example 13: An inhaler article according to any of Examples 1-12, wherein the inhalable material comprises nicotine. Example 14: An inhaler article according to any of Examples 1-13, wherein the end plug includes a central channel extending therethrough, the central channel configured to provide access to the cavity for the piercing element. Example 15: An inhaler system comprising an inhaler article according to any one of Examples 1 to 14 and a holder for receiving the inhaler article, wherein the holder includes a housing defining a housing cavity configured to receive the inhaler article, and a piercing element configured to extend into the housing cavity and pierce a capsule of the inhaler article.

[0123] The invention will now be further described with reference to the figures. [Brief explanation of the drawings]

[0124] [Figure 1] FIG. 1 is a cross-sectional view of an inhaler article of the present disclosure. [Figure 2] FIG. 2 is a cutaway perspective view of an inhaler article of the present disclosure. [Figure 3] FIG. 3 is a cross-sectional view of an inhaler system according to the present disclosure. [Figure 4] FIG. 4 is a plan view of the inhaler system. [Figure 5] FIG. 5 shows a front elevation view of a different embodiment of a filter segment for use in the inhaler article of the present disclosure. [Figure 6] FIG. 6 shows a front elevation view of a different embodiment of a filter segment for use in the inhaler article of the present disclosure. [Figure 7] FIG. 7 shows a front elevation view of a different embodiment of a filter segment for use in the inhaler article of the present disclosure. [Figure 8] FIG. 8 shows a front elevation view of a different embodiment of a filter segment for use in the inhaler article of the present disclosure. [Figure 9] FIG. 9 shows a front elevation view of a different embodiment of a filter segment for use in the inhaler article of the present disclosure. [Figure 10] FIG. 10 shows a front elevation view of a different embodiment of a filter segment for use in the inhaler article of the present disclosure. DETAILED DESCRIPTION OF THE INVENTION

[0125] 1 and 2 show an inhaler article 10 according to the present disclosure. The inhaler article 10 extends between its upstream end 1 and downstream (or mouth) end 2. The inhaler article 10 comprises an upstream section 3 and a downstream section 4 located downstream and spaced apart from the upstream section 3. A cavity 7 configured to receive a capsule 9 containing an inhalable material is located between the upstream section 3 and the downstream section 4 of the inhaler article 10. The inhalable material includes nicotine.

[0126] 1 and 2, the upstream section 3 includes an end plug 5, and the downstream section 4 includes a filter segment 6. The end plug 5 extends from the upstream end 1 of the inhaler article 10 to the cavity 7, or an upstream portion thereof. The filter segment 6 extends from the cavity 7, or a downstream portion thereof, to the downstream end 2 of the inhaler article 10.

[0127] The inhaler article 10 further comprises a hollow tubular element 12, a filter wrapper 14 surrounding the filter segment 6, and an overall wrapper 8 encasing both the hollow tubular element 12 and the filter segment 6. The hollow tubular element 12 encompasses both the end plug 5 and the cavity 7. The hollow tubular element 12, the downstream end of the end plug 5 of the upstream section 3, and the upstream end of the filter segment 6 define the cavity 7. The end plug 5 is retained within the hollow tubular element 12 by a tight or friction fit between the end plug 5 and the hollow tubular element 12. The downstream end of the hollow tubular element 12 abuts the upstream end of the filter segment 6 of the downstream section 4. The filter segment 6 and the filter wrapper 14 together form the downstream section 4. The overall wrapper 8 surrounds both the hollow tubular element 12 and the downstream section 4. The wrapper 8 is axially aligned with the hollow tubular element 12 to secure the downstream section 4.

[0128] In the embodiment shown in Figures 1 and 2, the total length of the inhaler article 10 is approximately 45 mm. The length of the end plug 5 is approximately 8 mm, the length of the cavity 7 is approximately 20 mm, and the length of the filter segment 6 is approximately 17 mm. The length of the hollow tubular element 12, which surrounds both the end plug 5 and the cavity 7, is approximately 25 mm to approximately 28 mm. The inner diameter of the hollow tubular element 12 is approximately 6.6 mm, and the outer diameter of the hollow tubular element 12 is approximately 7.1 mm. The length of the packaging material 8 is approximately 45 mm. The length of the filter wrapper 14 is approximately 17 mm. The diameter of the inhaler article 10 is approximately 7 mm. The relative RTD, or RTD per unit length, of the filter segment 6 is approximately 0.02 mm of water column per mm. The RTD of the filter segment 6 is approximately 0.34 mm of water column. The diameter of the capsule 9 is approximately 6 mm, and the length of the capsule 9 is approximately 16 mm.

[0129] End plug 5 defines a central channel or passageway 55 extending from the upstream end of end plug 5 through the center of the end plug 5 body. Central channel 55 of end plug 5 is open at its upstream end and closed at its downstream end by a resealable member 54. Central channel 55 and the downstream end of resealable member 54 are adjacent to cavity 7. Central channel 55 of end plug 5 is disposed to provide access to cavity 7 for a piercing element, as shown in FIG. 3 . Such a piercing element is configured to penetrate membrane 54, extend into cavity 7, and pierce or perforate capsule 9 to activate it for consumption. The length of central channel 55 is the same as the length of end plug 5. The diameter of central channel 55 is less than approximately 6 mm. The central channel is structured to accommodate a piercing element or needle measuring 27 gauge (outer diameter = 0.42 mm) to 4 gauge (outer diameter = 5 mm).

[0130] The end plug 5 includes at least one air flow inlet channel 51, 52 extending from the upstream end of the end plug 5 into the cavity 7 so that fluid communication can be established between the cavity 7 and the exterior of the inhaler article 10. As shown in FIG. 2 , the at least one air flow channel includes two air inlet channels 51, 52 extending along and partially around the outer surface of the end plug 5. The inlet channels 51, 52 extend in both the longitudinal and circumferential directions defined by the end plug 5. In other words, the inlet channels 51, 52 each extend in directions that diverge from a direction parallel to the longitudinal axes of the inhaler article 10 and the end plug 5. Thus, the inlet channels 51, 52 are non-parallel to the longitudinal axis of the inhaler article 10. The inlet channels 51, 52 follow a helical path around the end plug 7. As a result, the inlet channels 51, 52 are configured to generate a swirling airflow within the cavity 7. The swirling airflow is arranged to agitate and rotate the capsule 9 within the cavity 7 so that, when the capsule 9 is pierced, the inhalable material is released downstream towards the mouth or downstream end 2 of the inhaler article 10.

[0131] 3 and 4 show an inhaler system 100 comprising an inhaler article 10 and a holder or device 120 for receiving the inhaler article 10. The holder 120 includes a housing 122 defining a housing cavity configured to receive the inhaler article 10. The housing cavity 125 is arranged to receive the upstream end 1 of the inhaler article 10.

[0132] The holder 120 also includes a piercing element 110 configured to extend into the housing cavity 125 and pierce the capsule 9 of the inhaler article 10. During use, the piercing element 110 is disposed so as to be aligned with the longitudinal axis of the inhaler article 10 and the center of the central channel 55 of the end plug 5. As the inhaler article 10 is pushed further into the housing cavity 125 by the consumer, the piercing element 110 may extend into the cavity 7 of the inhaler article 10 by passing through the central channel 55 and the resealable member 54 of the end plug 5, as shown in FIG. 3 . Upon activation (or piercing) of the capsule 9, the consumer may suck on the mouth or downstream end 2 of the inhaler article 10 either when it is received within the holder 100, or when the inhaler article 10 is withdrawn from the holder 100 after capsule activation and the user obstructs the pierced central channel 55 so that air enters via the air inlet channels 51, 52.

[0133] The holder 120 also includes a marking element 130. The marking element 130 is arranged to mark or provide an indication on the outer wrapper 8 of the inhaler article 10 that the inhaler article 10 has been consumed. The marking element 130 may be activated in conjunction with activation of the piercing element 110.

[0134] The holder 120 may also include a sleeve 124 configured to hold the inhaler article 110 within a housing cavity 125. The sleeve 124 includes a sleeve cavity and is movable within the housing cavity 125 along the longitudinal axis of the housing 122 of the holder 100. The sleeve 124 includes a first open end and a second opposite end. The first open end is configured to receive the upstream end 1 of the inhaler article 10. The second opposite end of the sleeve 124 is configured to abut the upstream end 1 of the inhaler article 10. The piercing element 110 is disposed to extend through the second opposite end of the sleeve 124 to extend into the inhaler article 10 and ultimately pierce the capsule 9.

[0135] The piercing element 110 is secured within the holder housing 122 and is configured to extend along the longitudinal axis of the holder 120 into the housing cavity 125 and the sleeve cavity.

[0136] The holder 120 includes a spring element 115 arranged to bias the sleeve 124 and the inhaler article 10 positioned within the sleeve cavity, away from the piercing element 110, toward the entrance of the housing cavity 125. To activate the capsule, a consumer can push the inhaler article 10, and consequently the sleeve 124, further into the housing cavity to insert the piercing element 110 deeper into the inhaler article 10, ultimately activating the capsule 9 of the inhaler article 10. Upon proper activation or piercing of the capsule 9, the consumer may stop pushing the inhaler article 10, and the spring element 115 may push or bias the sleeve 124 and the inhaler article 10, away from the distal end of the housing cavity 125, toward the entrance of the housing cavity 125. The consumer may receive audible or tactile feedback that the capsule 9 has been successfully pierced by the piercing element 110.

[0137] The filter segment 6 of the inhaler article 10 includes at least one filter airflow channel 16 extending along the filter segment 6. FIG. 5 shows one embodiment of a filter segment 61 including a single Y-shaped airflow channel 161. The Y-shaped channel 161 can be considered to consist of three channels joined together by a central channel along the central axis of the filter segment 61 to form the single Y-shaped airflow channel 161. The cross-sectional area of ​​the airflow channel 161 is at least 25% of the total cross-sectional area of ​​the filter segment 61. The filter segment 61 is formed from cellulose acetate tow or other suitable material. The RTD per unit length of the filter segment 61 is approximately 0.02 mm of water column per mm.

[0138] Figure 6 shows one embodiment of a filter segment 62 that includes three airflow channels 162. As shown in Figure 6, the airflow channels 162 are circular and arranged in a triangular configuration. The total cross-sectional area of ​​the airflow channels 162 is at least 10% of the total cross-sectional area of ​​the filter segment 62. The filter segment 62 is formed from cellulose acetate tow or other suitable material.

[0139] Figure 7 shows one embodiment of a filter segment 63 that includes five airflow channels 163. As shown in Figure 7, the airflow channels 163 are in the shape of annular sectors and are evenly distributed circumferentially about the outer periphery of the filter segment 63. The total cross-sectional area of ​​the airflow channels 163 is at least 10% of the total cross-sectional area of ​​the filter segment 63. The filter segment 63 is formed from cellulose acetate tow or other suitable material. The RTD per unit length of the filter segment 63 is approximately 0.05 mm of water column per mm.

[0140] 8 shows one embodiment of a filter segment 64 that includes seven airflow channels 164. The total cross-sectional area of ​​the airflow channels 164 is at least 75% of the total cross-sectional area of ​​the filter segment 64. The filter segment 64 is formed from a bioplastic material. The RTD per unit length of the filter segment 64 is approximately 0.01 mm of water column per mm.

[0141] 9 shows one embodiment of a filter segment 65 formed from a bundle of polylactic acid fibers extending longitudinally along the filter segment 65. Gaps (not shown) between the fibers effectively provide airflow channels. The cross-sectional area of ​​the filter segment 65 occupied by the fibers is at least about 95% of the total cross-sectional area of ​​the filter segment 65. The RTD per unit length of the filter segment 65 is about 0.6 mm of water per mm.

[0142] 10 shows one embodiment of a filter segment 65 comprising a roll of a crimped sheet of paper-based material. Longitudinal gaps within the rolled, crimped sheet material are defined throughout the length of the filter segment 65. The RTD per unit length of the filter segment 65 is approximately 0.25 mm of water per mm.

[0143] For purposes of this specification and the appended claims, unless otherwise indicated, all numbers expressing amounts, quantities, percentages, and the like should be understood in all instances to be modified by the term "about." Also, all ranges include the disclosed maximum and minimum points, and include any intermediate ranges therein, which may or may not be specifically recited herein. Thus, in this context, the number A is understood as A ± 10%. Within this context, the number A may be considered to include values ​​that are within the general standard error for measurement of the property that the number A modifies. In some cases, such as when used in the appended claims, the number A may deviate by the percentages recited above, provided that the amount by which A deviates does not materially affect the basic and novel characteristics of the claimed invention. Also, all ranges include the disclosed maximum and minimum points, and include any intermediate ranges therein, which may or may not be specifically recited herein.

Claims

1. 1. An inhaler article having an upstream end and a downstream end, the inhaler article comprising: an upstream section, the upstream section including an end plug; a downstream section located downstream of the upstream section and spaced apart from the upstream section, the downstream section including a filter segment, the filter segment having a pull-out resistance per unit length greater than 0 millimeters of water column per millimeter and less than 3 millimeters of water column per millimeter, the filter segment configured to withstand a force of up to 15 Newtons applied to its upstream end without substantial deformation; a cavity defined between the upstream section and the downstream section, the cavity configured to be in fluid communication with an exterior of the inhaler article; and a capsule containing an inhalable material, said capsule positioned within said cavity.

2. 10. The inhaler article of claim 1, wherein the resistance to withdrawal per unit length of the filter segment is greater than 0 millimeters of water column per millimeter and less than 1 millimeter of water column per millimeter.

3. 3. The inhaler article of claim 1, wherein the filter segment has a Young's modulus greater than 10 MPa.

4. The inhaler article of any of claims 1 to 3, wherein the resistance to withdrawal of the filter segment is greater than 0 millimeters of water column and less than 10 millimeters of water column.

5. The inhaler article of any one of claims 1 to 4, wherein the length of the filter segment is between 10 millimeters and 20 millimeters.

6. The inhaler article of any of claims 1 to 5, wherein the filter segment extends from the cavity to the downstream end of the inhaler article.

7. The inhaler article of any of claims 1 to 6, further comprising a hollow tubular element extending from the upstream end of the inhaler article to the filter segment, the end plug and the capsule being located within the hollow tubular element.

8. 8. The inhaler article of claim 7, wherein the inhaler article comprises a wrapping material surrounding the hollow tubular element and the downstream section, the wrapping material securing the downstream section in axial alignment with the hollow tubular element.

9. The inhaler article of any one of claims 1 to 8, wherein the end plug defines at least one air flow inlet channel extending from the upstream end of the end plug to the cavity such that fluid communication is established between the cavity and the exterior of the inhaler article.

10. 10. The inhaler article of claim 9, wherein the at least one air flow inlet channel comprises two air flow inlet channels configured to generate a swirling air flow within the cavity.

11. The inhaler article of any of claims 1 to 10, wherein the filter segment comprises at least one filter airflow channel extending along the filter segment.

12. The inhaler article of any of claims 1 to 11, wherein the inhalable material comprises nicotine.

13. 13. The inhaler article of any of claims 1-12, wherein the end plug includes a central channel extending through a body of the end plug, the central channel configured to provide access to the cavity for a piercing element.

14. An inhaler system comprising an inhaler article according to any one of claims 1 to 13 and a holder for receiving the inhaler article, wherein the holder: a housing defining a housing cavity configured to receive the inhaler article; a piercing element extending into the housing cavity and configured to pierce the capsule of the inhaler article.

Images